Mabtech, Sai Life Sciences Partner to Expand Advanced Immunology Services in the U.S.
Mabtech and Sai Life Sciences collaborate to deploy EYRA multiplex platform in Boston, enhancing access to advanced immune profiling for biopharma and biotech research.
Sai Life Sciences | 19/03/2026 | By News Bureau | 103
Mabtech and Sai Life Sciences Partner to Advance Immunology Research
Under this collaboration, Mabtech and Sai will jointly deliver advanced immunology assay services — including high-sensitivity multiplex cytokine and phenotyping workflows — powered by the EYRA platform installed at Sai’s Boston discovery site.
Sai Life Sciences | 31/01/2026 | By News Bureau
Sai Life Sciences Set to Double Process R&D Capacity with New Facility in Hyderabad
The upcoming Process R&D Block at Sai Life Sciences will cover 100,000 sq. ft. across five floors, featuring 140 process chemistry fume hoods, an integrated satellite analytical lab, and dedicated peptide and oligo labs, supported by a 25,000 sq. ft. central analytical facility.
Sai Life Sciences | 28/10/2025 | By Dineshwori | 249
Through the partnership among Sai Life Sciences, Agility Life Sciences and Centrix Pharma Solutions, customers will have access to integrated drug substance and drug product development, helping them move efficiently from pre-clinical studies to First-In-Human (FIH) clinical trials and beyond.
Sai Life Sciences | 09/10/2025 | By Dineshwori | 146
Sai Life Sciences Completes Phase-II of Production Block 11 at Bidar site
Sai Life Sciences’ Unit IV in Bidar is the company’s flagship manufacturing site, specialising in the production of APIs and advanced intermediates for markets such as the US, EU and Japan.
Sai Life Sciences | 29/08/2025 | By Dineshwori | 385
Sai Life Sciences Establishes Peptide Research Centre in Hyderabad
Sai Life Sciences has inaugurated a state-of-the-art Peptide Research Centre at its Hyderabad R&D campus, expanding its capabilities in complex peptide synthesis and conjugation to support next-generation therapeutics.
Sai Life Sciences | 04/04/2025 | By Abha | 286
Sai Life Sciences Eyes Global Expansion as Revenue Hits INR 1,115.1 Crore
The company reported a 15 percent increase in revenue and a 36 percent rise in net profit compared to the same period last year, driven by strong execution, expanding capacity, and deepening customer relationships.
Sai Life Sciences | 10/02/2025 | By Aishwarya | 1011
Sai Life Sciences unveils opens research facility for Schrodinger in Hyderabad
In January 2023, Sai Life Sciences entered into a five-year strategic agreement with Schrodinger
Sai Life Sciences | 21/04/2023 | By Sudeep Soparkar | 918
Sai Life Sciences unveils GMP Kilo Lab in Alderley Park, Manchester, UK
The new GMP Kilo Lab will enable Sai Life Sciences to offer drug substances and intermediates supplies ranging from gram to kilogram quantities
Sai Life Sciences | 16/03/2023 | By Sudeep Soparkar | 670
Sai Life Sciences opens high-potency API manufacturing facility at Bidar Campus
The facility is spread across 16000 sq ft HPAPI block
Sai Life Sciences | 17/01/2023 | By Sudeep Soparkar | 1476
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy